Salem Radio Network News Thursday, May 13, 2021


Sanofi, Glaxo advance talks to supply up to 300 mln COVID-19 vaccine does to Europe -companies

(Reuters) – Sanofi SA and GlaxoSmithKline Plc on Friday said they are in advanced discussions with the European Commission to supply up to 300 million doses of the drugmakers’s experimental COVID-19 vaccine.

The doses would be manufactured in European countries including France, Belgium, Germany and Italy.

Sanofi is leading the clinical development of the vaccine and expects to launch a pivotal trial by the end of this year.

(Reporting By Deena Beasley; editing by Grant McCool)


Editorial Cartoons

View More »

Gary Varvel
Fri, May 7, 2021